Perioperative variables associated with surgical site infection in breast cancer surgery

Journal of Hospital Infection

Volumn 79, Issue 4, 2011, Pages 328-332

  Angarita, F A ^a   Acuna, S A ^a   Torregrosa, L ^a,b   Tawil, M ^a,b   Escallon, J ^c   Ruiz T A ^d  

^a HOSPITAL UNIVERSITARIO SAN IGNACIO   (Colombia)

^b Breast and Soft Tissue Clinic   (Colombia)

^c MOUNT SINAI HOSPITAL   (Canada)

^d PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

Author keywords

Breast cancer; Breast surgery; Surgical site infection

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BODY MASS; BREAST CANCER; BREAST RECONSTRUCTION; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DATA ANALYSIS; DATA EXTRACTION; DIABETES MELLITUS; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL HISTORY; MEDICAL RECORD; PERIOPERATIVE PERIOD; POSTOPERATIVE INFECTION; PREOPERATIVE PERIOD; SKIN DISEASE; SMOKING; UNIVERSITY HOSPITAL;

ADULT; AGED; BREAST NEOPLASMS; DIABETES COMPLICATIONS; FEMALE; HUMANS; MIDDLE AGED; RISK FACTORS; SKIN DISEASES; SMOKING; SURGICAL WOUND INFECTION;

EID: 81055156568     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2011.08.006     Document Type: Article

References (49)

1. Cruse P.J.E., Foord R. The epidemiology of wound infection. A 10-year prospective study of 62,939 wounds. Surg Clin North Am 1980, 6:27-40.
2. National Nosocomial Infection Surveillance System National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004, 32:470-485.
3. Hall J.C., Hall J.L. Antibiotic prophylaxis for patients undergoing breast surgery. J Hosp Infect 2000, 46:165-170.
4. Broadwater J.R., Edwards M.J., Kuglen C., Hortobagyi G.N., Ames F.C., Balch C.M. Mastectomy following preoperative chemotherapy: strict operative criteria control operative morbidity. Ann Surg 1991, 213:126-129.
5. Canavese G., Catturich A., Vecchio C., et al. Surgical complications related to peri-operative adjuvant chemotherapy in breast cancer: results of a prospective, controlled, randomized clinical trial. Eur J Surg Oncol 1997, 23:10-12.
6. Furey P.C., Macgillivray D.C., Castiglione C.L., Allen L. Wound complications in patients receiving adjuvant chemotherapy after mastectomy and immediate breast reconstruction for breast cancer. J Surg Oncol 1994, 55:194-197.
7. Coello R., Glenister H., Fereres J., et al. The cost of infection in surgical patients: a case control study. J Hosp Infect 1993, 25:239-250.
8. Tejirian T., DiFronzo A., Haigh P.I. Antibiotic prophylaxis for preventing wound infection after breast surgery: a systematic review and metaanalysis. J Am Coll Surg 2006, 203:729-734.
9. D'Amico D.F., Paimbelli P., Ruffolo C. Antibiotic prophylaxis in clean surgery: breast and hernia reapair. J Chemother 2001, 13:108-111.
10. Witt A., Yavuz D., Walchetseder C., Strohmer H., Kubista E. Preoperative core needle biopsy as an independent risk factor for wound infection after breast surgery. Obstet Gynecol 2003, 101:745-750.
11. Rotstein C., Ferguson R., Cummings K.M., Piedmonte M.R., Lucey J., Banish A. Determinants of clean surgical wound infections for breast procedures at an oncology center. Infect Control Hosp Epidemiol 1992, 13:207-214.
12. Lefebvre D., Penel N., Deberles M.F., Fournier C. Incidence and surgical wound infection risk factors in breast cancer surgery. Presse Med 2000, 29:1927-1932.
13. Platt R., Zucker J.R., Zaleznik D.F., et al. Prophylaxis against wound infection following herniorrhaphy or breast surgery. J Infect Dis 1992, 166:556-560.
14. Bertin M.L., Crowe J., Gordon S.M. Determinants of surgical site infection after breast surgery. Am J Infect Control 1998, 26:61-65.
15. Bundred N., Maguire P., Reynolds J., et al. Randomised controlled trial of effects of early discharge after surgery for breast cancer. BMJ 1998, 317:1275-1279.
16. Angarita F.A., Acuna S.A., Torregrosa T., Tawil M., Ruiz A. Initial presentation of patients diagnosed with breast cancer at the hospital Universitario San Ignacio - Centro Javeriano de Oncología. Rev Colomb Cir 2010, 25:19-26.
17. Mangram A.J., Horan T.C., Pearson M.L., Silver L.C., Jarvis W.R. Guidelines for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999, 20:250-278.
18. Horan T.C., Gaynes R.P., Martone W.J., Jarvis W.R., Emori T.G. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992, 13:606-608.
19. Angarita F.A., Acuna S.A., Torregrosa L., et al. Bilateral necrotizing fasciitis of the breast following quadrantectomy. Breast Cancer 2010 Sep 3, [Epub ahead of print].
20. Vilar-Compte D., Jacquemin B., Robles-Vidal C., Volkow P. Surgical site infections in breast cancer surgery: case-control study. World J Surg 2004, 28:242-246.
21. Olsen M.A., Chu-Ongsakul S., Brandt K.E., Dietz J.R., Mayfield J., Fraser V.J. Hospital-associated costs due to surgical site infection after breast surgery. Arch Surg 2008, 143:53-61.
22. Felippe W.A., Werneck G.L., Santoro-Lopes G. Surgical site infection among women discharged with a drain in situ after breast cancer surgery. World J Surg 2007, 31:2293-2301.
23. Badr el Din A., Coibion M., Guenier C., et al. Local postoperative morbidity following pre-operative irradiation in locally advanced breast cancer. Eur J Surg Oncol 1989, 15:486-489.
24. Sauter E.R., Eisenberg B.L., Hoffman J.P., et al. Postmastectomy morbidity after combination preoperative irradiation and chemotherapy for locally advanced breast cancer. World J Surg 1993, 17:237-241.
25. Skinner K.A., Dunnington G., Silberman H., Florentine B., Spicer D., Formenti S.C. Preoperative 5-fluorouracil and radiation therapy for locally advanced breast cancer. Am J Surg 1997, 174:705-708.
26. Huang E., Mcneese M.D., Strom E.A., et al. Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancer. Int J Radiat Oncol Biol Phys 2000, 2:1225-1233.
27. Weiss C.A., Statz C.L., Dahms R.A., Remucal M.J., Dunn D.L., Beilman G.J. Six years of surgical wound infection surveillance at a tertiary care center: review of the microbiologic and epidemiological aspects of 20,007 wounds. Arch Surg 1999, 134:1041-1048.
28. Seltzer M.H. Partial mastectomy and limited axillary dissection performed as same day surgical procedure in the treatment of breast cancer. Int Surg 1995, 80:79-81.
29. Keidan R.D., Hoffman J.P., Weese J.L., et al. Delayed breast abscesses after lumpectomy and radiation therapy. Am Surg 1990, 56:440-444.
30. Tejler G., Aspegren K. Complications and hospital stay after surgery for breast cancer: a prospective study of 385 patients. Br J Surg 1985, 72:542-544.
31. Tran C.L., Langer S., Broderick-Villa G., DiFronzo L.A. Does reoperation predispose to postoperative wound infection in women undergoing operation for breast cancer?. Am Surg 2003, 69:852-856.
32. Nieto A., Lozano M., Moro M.T., Keller J., Carralafuente C. Determinants of wound infections after surgery for breast cancer. Zentralbl Gynakol 2002, 124:429-433.
33. Chen J., Gutkin Z., Bawnik J. Postoperative infections in breast surgery. J Hosp Infect 1991, 17:61-65.
34. Lipshy K.A., Neifeld J.P., Boyle R.M., et al. Complications of mastectomy and their relationship to biopsy technique. Ann Surg Oncol 1996, 3:290-294.
35. Hayes J.A., Bryan R.M. Wound healing following mastectomy. Aust NZ J Surg 1984, 54:25-27.
36. Say C.C., Donegan W. A biostatistical evaluation of complications from mastectomy. Surg Gynecol Obstet 1974, 138:370-376.
37. Rey J.E., Gardner S.M., Cushing R.D. Determinants of surgical site infection after breast biopsy. Am J Infect Control 2005, 33:126-129.
38. Olsen M.A., Lefta M., Dietz J.R., et al. Risk factors for surgical site infection after major breast operation. J Am Coll Surg 2008, 207:326-335.
39. Pittet B., Montandon D., Pittet D. Infection in breast implants. Lancet Infect Dis 2005, 5:94-106.
40. He X.D., Guo Z.H., Tian J.H., Yang K.H., Xie X.D. Whether drainage should be used after surgery for breast cancer? A systematic review of randomized controlled trials. Med Oncol 2010 Sep 9, [Epub ahead of print].
41. Lawrence W.T., Talbot T.L., Norton J.A. Preoperative or postoperative doxorubicin hydrochloride (adriamycin): which is better for wound healing?. Surgery 1986, 100:9-13.
42. Warren Peled A., Itakura K., Foster R.D., et al. Breast reconstruction impact of chemotherapy on postoperative complications after mastectomy and immediate breast reconstruction. Arch Surg 2010, 145:880-885.
43. Ruvalcaba-Limon E., Robles-Vidal C., Poitevin-Chacon A., Chávez-Macgregor M., Gamboa-Vignolle C., Vilar-Compte D. Complications after breast cancer surgery in patients treated with concomitant preoperative chemoradiation: a case-control analysis. Breast Cancer Res Treat 2006, 95:147-152.
44. Alderman A.K., Wilkins E.G., Kim H.M., Lowery J.C. Complications in postmastectomy breast reconstruction: two-year results of the Michigan breast reconstruction outcome study. Plast Reconstr Surg 2002, 109:2265-2274.
45. Ringberg A., Tengrup I., Aspegren K., Palmer B. Immediate breast reconstruction after mastectomy for cancer. Eur J Surg Oncol 1999, 25:470-476.
46. Simpson S.A., Ying B.L., Ross L.A., et al. Incidence of complications in outpatient mastectomy with immediate reconstruction. J Am Coll Surg 2007, 205:463-467.
47. Azzawi K., Ismail A., Earl H., Forouhi P., Malata C.M. Influence of neoadjuvant chemotherapy on outcomes of immediate breast reconstruction. Plast Reconstr Surg 2010, 126:1-11.
48. Mortenson M.M., Schneider P.D., Khatri V.P., et al. Immediate breast reconstruction after mastectomy increases wound complications. Arch Surg 2004, 139:988-991.
49. Bunn F., Cunningham M.E., Handscomb K. Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery. Cochrane Database Syst Rev 2006, 2.